Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways

Cancer Letters

Volumn 254, Issue 2, 2007, Pages 217-226

  Shanker, Manish ^a   Gopalan, Began ^a   Patel, Suraag ^a   Bocangel, Dora ^b   Chada, Sunil ^b   Ramesh, Rajagopal ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Introgen Therapeutics Inc   (United States)

Author keywords

Apoptosis; Cancer; MDA 7; Tocopherol; VES

Indexed keywords

ADENOVIRUS VECTOR; ALPHA TOCOPHEROL SUCCINATE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIGEN; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 7; PROTEIN BID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; COXSACKIE VIRUS; DOSE RESPONSE; DRUG POTENTIATION; DRUG SELECTIVITY; ENZYME RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR CELL DESTRUCTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROVIRUS; FEMALE; HUMANS; INTERLEUKINS; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; OVARIAN NEOPLASMS; RECEPTORS, VIRUS; VITAMIN E;

ADENOVIRIDAE;

EID: 34547158147     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.03.004     Document Type: Article

References (32)

1. Greenlee R., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 2000. CA Cancer J. Clin. 50 (2000) 7-33
2. Faivre S., Djelloul S., and Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin. Oncol. 33 (2006) 407-420
3. Neuzil J., Kagedal K., Andera L., Weber C., and Brunk U.T. Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 7 (2002) 179-187
4. Weber T., Lu M., Andera L., Lahm H., Gellert N., Fariss M.W., et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin. Cancer Res. 8 (2002) 863-869
5. Barnett K.T., Fokum F.D., and Malafa M.P. Vitamin E succinate inhibits colon cancer liver metastases. J. Surg. Res. 106 (2002) 292-298
6. Neuzil J., Weber T., Gellert N., and Weber C. Selective cancer cell killing by alpha-tocopherol succinate. Br. J. Cancer 84 (2000) 87-89
7. Lawson K.A., Anderson K., Menchaca M., Atkinson J., Sun L., Knight V., et al. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol. Cancer Ther. 2 (2003) 437-444
8. Malafa M.P., and Neitzel L.T. Vitamin E succinate promotes breast cancer tumor dormancy. J. Surg. Res. 93 (2000) 163-170
9. Israel K., Yu W., Sanders B.G., and Kline K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr. Cancer 36 (2000) 90-100
10. Weber T., Dalen H., Andera L., Negre-Salvayre A., Auge N., Sticha M., et al. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 42 (2003) 4277-4291
11. Yu W., Shun M.C., Anderson K., Chen H., Sanders B.G., and Kline K. Alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis 11 (2006) 1813-1823
12. Malafa M.P., Fokum F.D., Smith L., and Louis A. Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate. Ann. Surg. Oncol. 9 (2002) 1023-1032
13. Tomasetti M., Rippo M.R., Alleva R., Moretti S., Andera L., Neuzil J., et al. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. Br. J. Cancer 90 (2004) 1644-1653
14. Chada S., Sutton R.B., Ekmekcioglu S., Ellerhorst J., Mumm J.B., Leitner W.W., et al. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family. Int. Immunopharmacol. 4 (2004) 649-667
15. Inoue S., Shanker M., Miyahara R., Gopalan B., Patel S., Oida Y., et al. MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinic. Curr. Gene Ther. 6 (2006) 73-91
16. Inoue S., Hartman A., Branch C.D., Bucana C.D., Bekele B.N., Stephens L.C., et al. mda-7 in combination with Bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft. Mol. Ther. 15 (2007) 287-294
17. Saeki T., Mhashilkar A., Swanson X., Zou-Yang X.H., Sieger K., Kawabe S., et al. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 21 (2002) 4558-4566
18. Ramesh R., Mhashilkar A., Tanaka F., Saito Y., Branch C.D., Seiger K., et al. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. 63 (2003) 5105-5113
19. Caudell E.G., Mumm J.B., Poindexter N., Ekmekcioglu S., Mhashilkar A.M., Yang X.H., et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 168 (2002) 6041-6046
20. Miyahara R., Banerjee S., Kawano K., Efferson C., Tsuda N., Miyahara Y., et al. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. Cancer Gene Ther. 13 (2006) 753-761
21. Chada S., Mhashilkar A., Ramesh R., Mumm J.B., Sutton R.B., Bocangel D., et al. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism. Mol. Ther. 10 (2004) 1085-1095
22. Zheng M., Bocangel D., Doneske B., Mhashilkar A., Ramesh R., Hunt K.K., et al. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol. Immunother. 56 (2007) 205-215
23. Kawabe S., Nishikawa T., Munshi A., Roth J.A., Chada S., and Meyn R.E. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol. Ther. 6 (2002) 637-644
24. Oida Y., Gopalan B., Miyahara R., Inoue S., Branch C.D., Mhashilkar A.M., et al. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol. Cancer Ther. 4 (2005) 291-304
25. Bocangel D., Zheng M., Mhashilkar A., Liu Y., Ramesh R., Hunt K.K., et al. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Cancer Gene Ther. 13 (2006) 958-968
26. McKenzie T., Liu Y., Fanale M., Swisher S.G., Chada S., and Hunt K.K. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery 136 (2004) 437-442
27. Yacoub A., Mitchell C., Hong Y., Gopalkrishnan R.V., Su Z.Z., Gupta P., et al. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells. Cancer Biol. Ther. A3 (2004) 739-751
28. Gopalan B., Litvak A., Sharma C., Mhashilkar A.M., Chada S., and Ramesh R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res. 65 (2005) 3017-3024
29. Saeki T., Mhashilkar A., Chada S., Branch C., Roth J.A., and Ramesh R. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther. 7 (2000) 2051-2057
30. Mhashilkar A.M., Schrock R.D., Hindi M., Liao J., Sieger K., Kourouma F., et al. Melanoma-differentiation associated gene-7 (mda-7): a novel antitumor gene for cancer gene therapy. Mol. Med. 7 (2001) 271-282
31. Fulda S., and Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 (2006) 4798-4811
32. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312